MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ALT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Altimmune (ALT) Ownership - Who owns Altimmune?

Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Miscellaneous Commercial Services
Address
910 Clopper Road
Phone
+1 240 654-1450
Employees
57
Web
https://www.altimmune.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
509.52M
P/E Ratio
N/A
Total Cash
331.54M
Projected Growth
N/A
Total Debt
35.85M
Revenue
36K
Risk (Beta)
3.25
Dividend Yield
N/A
Total Cash/Share
1.70
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ALT
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ALT
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Details
Industry
Miscellaneous Commercial Services
Address
910 Clopper Road
Phone
+1 240 654-1450
Employees
57
Web
https://www.altimmune.com